Location History:
- Chicago, IL (US) (2011)
- Carlsbad, CA (US) (2011)
- Cambridge, MA (US) (2013)
- Oakland, CA (US) (2016)
Company Filing History:
Years Active: 2011-2016
Title: The Innovative Contributions of Prasad Dande in Gene Modulation
Introduction
Prasad Dande, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of gene modulation. With three patents to his name, his work has the potential to shape advancements in therapeutic methodologies and genetic research.
Latest Patents
Among his recent inventions is the patent for "Positionally modified siRNA constructs." This invention outlines oligomeric compounds capable of hybridizing to nucleic acid targets, enhancing gene expression modulation. These compounds include double-stranded constructs featuring modified ribofuranosyl nucleosides at defined locations, boosting the efficacy of gene-related applications. Another notable patent is for "Oligomeric compounds comprising 4'-thionucleosides for use in gene modulation." This invention introduces modified oligomeric compounds, particularly siRNA and asRNA, that are employed in the RNA interference pathway to facilitate gene modulation.
Career Highlights
Prasad Dande is currently affiliated with Isis Pharmaceuticals, Inc., an organization known for its innovative research and development in the biopharmaceutical sector. His role has allowed him to leverage cutting-edge technologies and contribute to impactful projects in genetic engineering.
Collaborations
Throughout his career, Prasad has collaborated with esteemed colleagues such as Balkrishen Bhat and Thazha P Prakash. These partnerships have enabled a dynamic exchange of ideas and fostered advancements in their respective areas of research.
Conclusion
Prasad Dande exemplifies the spirit of innovation in the scientific community. His focus on gene modulation through inventive approaches demonstrates the potential to transform therapeutic interventions. As he continues to develop new technologies, his contributions are likely to play a crucial role in the future of genetic research and biopharmaceutical advancements.